Search results
Two Philadelphia-area biotech firms report progress on pursuit of a hepatitis B cure - Philadelphia...
The Business Journals· 1 day agoTwo local life sciences companies reported progress this week on their efforts to develop a cure for...
Arbutus' Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity...
Benzinga· 2 days agoAt the end of treatment, 33.3% of patients receiving imdusiran for 48 weeks, interferon (IFN) for 24 weeks and ongoing nucleoside analogue (NA) therapy achieved undetectable levels of HBsAg that were maintained in 100%
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 1 day agoKashyap Patel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
Transgenic murine model expresses BCP-mutated hepatitis B virus genome
Medical Xpress· 2 days agoChronic hepatitis B virus (HBV) infection can lead to advanced liver pathology. HBV has been infecting humans for over 10,000 years, with coordinated viral gene expression to establish persistent infection.
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Finance· 24 hours agoTobevibart is an investigational subcutaneously administered antibody designed to inhibit entry of ...
GSK acquires Elsie to unlock oligonucleotide therapeutics
Pharmaceutical Technology via Yahoo Finance· 9 hours agoGSK chief scientific officer Tony Wood stated: “We have already made great strides in...
Is It Safe to Breastfeed If There Is Blood In Breast Milk?
Parents via Yahoo News· 3 days agoUnderstand what conditions might cause blood to appear in breastmilk, and if it's safe to continue...
GSK acquires oligonucleotide drug startup Elsie
BioPharma Dive via Yahoo Finance· 1 day agoGSK’s efforts around oligonucleotides also coincide with the company’s pivot away from cell therapies. One of its most advanced candidates comes from...
LGBTQ+ population faces greater cancer risks. Also faces barriers to care, studies show.
USA TODAY via Yahoo News· 4 days agoCorrection: This story was updated to reflect that hepatitis B vaccinations were higher among LGBTQ+ people than heterosexual adults. LGBTQ+ people are ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 2 days agoVirion Therapeutics Reports Positive First-in-human, First-in-class, Phase 1b Immunogenicity Data of VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure at EASL Congress PR Newswire PHILADELPHIA, June 5, 2024 Highlights from the Data
